FundedIQ
Biotechnology

Pearl Diagnostics: Funding, Investors & Team (Sep 2026)

Pearl Diagnostics develops diagnostic products to enable early detection and prevent lung infections. It was founded in 2014 in the Johns Hopkins Fast Forward Accelerator in Baltimore, Maryland.

pearldx.com LinkedIn Baltimore, United States 1-10 employees
Biotechnology Health Diagnostics Medical Medical Device
Total raised
$11.2M
Rounds
1
Latest
Undisclosed round
Apr 2026

Pearl Diagnostics has raised $11.2M across 1 funding round on record, the most recent an undisclosed round of $11.2M announced in Apr 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Pearl Diagnostics Company Profile and Key Stats

Total funding raised
$11.2M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$11.2M in Apr 2026
Employees
1-10
reported band
Headquarters
Baltimore, United States

Latest funding round on record: Apr 2026.

Pearl Diagnostics Funding Rounds

Date
Round
Amount
Undisclosed round
$11.2M

Pearl Diagnostics Founders and Leadership Team

Name
Role
Contact
Dewayne Davenport
Founder
Locked

Contact details for the Pearl Diagnostics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Pearl Diagnostics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Pearl Diagnostics' latest round of $11.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Pearl Diagnostics in Biotechnology and Baltimore

Companies Similar to Pearl Diagnostics

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Pearl Diagnostics Funding FAQs

What does Pearl Diagnostics do?

Pearl Diagnostics develops diagnostic products to enable early detection and prevent lung infections. It was founded in 2014 in the Johns Hopkins Fast Forward Accelerator in Baltimore, Maryland.

How much funding has Pearl Diagnostics raised?

Pearl Diagnostics has raised $11.2M across 1 round on record. The most recent is an undisclosed round of $11.2M announced in Apr 2026.

When did Pearl Diagnostics last raise funding?

Pearl Diagnostics' most recent funding round on record is an undisclosed round of $11.2M, announced in Apr 2026.

Who founded Pearl Diagnostics?

FundedIQ lists Dewayne Davenport (Founder) at Pearl Diagnostics.

Where is Pearl Diagnostics headquartered?

Pearl Diagnostics is based in Baltimore, Maryland, United States.

How many employees does Pearl Diagnostics have?

Pearl Diagnostics is in the 1-10 employee band.

How does Pearl Diagnostics' funding compare to other Biotechnology startups?

Pearl Diagnostics' latest round of $11.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Pearl Diagnostics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pearl Diagnostics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.